Roche Holding AG (Roche) is a research-based healthcare company that develops, manufactures and delivers medicines, and diagnostic instruments and tests. The company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The company develops medicines for the disease areas, including oncology, immunology, infectious diseases, ophthalmology, and neuroscience.
Roche’s environmental strategy encompasses three primary foci: greenhouse gas reductions, renewable energy utilization, and mitigating hazardous substances from entering the air, water, and surrounding landscape. The company implements a range of energy efficiency and toxic emission management technologies, which significantly reduce the release of VOCs, NOx, and SOx during manufacturing. Roche is a member of the Pharmaceuticals Supply Chain Initiative and sets a high bar for the environmental performance of its suppliers. In addition to the environment, Roche has a number of initiatives in place to address health care disparities, including personalized reimbursement models, differential pricing, patient assistance programs and private insurance offerings. For example, the company is heavily involved in efforts to provide greater access to its HIV diagnostic products and has made many of these technologies available for a drastically reduced prices in Sub-Saharan Africa and other developing nations. Roche also offers employees significant benefits and opportunities, such as discounted stock purchase plans and an international job rotation program between leaders within the company.
Despite some best practices with regard to product quality such as international certifications and membership to recognized industry partnerships, Roche faces continued product recalls, displaying a need for more effective management systems and compliance monitoring.
Industry: Health Care
To the best of our knowledge the above information is accurate and was obtained from sources we believe to be reliable. Neither the information presented above nor any opinion expressed shall be construed as an offer to sell or a solicitation to buy the security. The views expressed are those of portfolio management as of 12/31/16 and may not reflect current opinions or subsequent events.